Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Clinical trial NCT01822496 · TERMINATED
Trial details
- NCT number
- NCT01822496
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-04
- Primary completion
- 2018-06-04
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.